WEST PALM BEACH, Fla, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW) , (“Rennova” or the “Company”) a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers that acquired its second rural hospital in Tennessee on June 1, 2018, announces completion of installation and training for a state of the art GE LightSpeed VCT 64 slice CT Scanner.
The high image resolution and acquisition speed of the new CT scanner is ideal for angiography, cardiac neuro, pediatric, pulmonary and trauma when freezing of cardiovascular motion, pure arterial phase imaging, and superior Multiplanar reformats are key features. The new CT Scanner will substantially improve both patient care and revenue streams.
“In keeping with our motto, ‘better service for my community’, said Hal Leftwich, CEO, Big South Fork Medical Center, “we are proud to offer this step forward in technology, with the additional studies and enhanced diagnostic capabilities. This investment by Rennova will now enable us to attract outside patient referrals, and in doing so boost revenue at Big South Fork Medical Center”.
Big South Fork Medical Center opened on August 8, 2017, with services that include a 24/7 emergency department along with radiology services that include X-ray, CT scan, ultrasound, nuclear medicine and MRI. Other available services include a laboratory, respiratory therapy, physical therapy, a medical/surgical unit and swing beds.
About Rennova Health, Inc.
Rennova provides industry-leading diagnostics and supportive software solutions to healthcare providers, delivering an efficient, effective patient experience and superior clinical outcomes. Through an ever-expanding group of strategic brands that work in unison to empower customers, we are creating the next generation of healthcare. For more information, please visit www.rennovahealth.com .
Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these and other risk factors are contained in the Company’s most recent filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.
Contacts: Rennova Health, Inc. Sebastien Sainsbury, 561-666-9818 ssainsbury@rennovahealth.com
